Want to see IN:AUROPHARMA full AI Analyst Report?
Aurobindo Pharma Ltd (AUROPHARMA) Stock Forecast & Price Target
AUROPHARMA Analyst Ratings
There are no analyst ratings in the last 3 months.
AUROPHARMA Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts​
AUROPHARMA Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, AUROPHARMA has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. AUROPHARMA average Analyst price target in the past 3 months is ―.
AUROPHARMA Financial Forecast
AUROPHARMA Earnings Forecast
Next quarter’s earnings estimate for AUROPHARMA is INR 19.37 with a range of INR 18.04 to INR 21.31. The previous quarter’s EPS was INR 17.86. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.
AUROPHARMA Sales Forecast
Next quarter’s sales forecast for AUROPHARMA is INR 98.24B with a range of INR 96.19B to INR 102.80B. The previous quarter’s sales results were INR 91.50B. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.
